Ubiquitin-specific peptidase 49 promotes adenocarcinoma of the esophagogastric junction malignant progression via activating SHCBP1– β -catenin–GPX4 axis
Carcinogenesis · 2025
DOI: 10.1093/carcin/bgae060 ↗Kurz gefasst
Fachartikel in der Zeitschrift Carcinogenesis, 2025. Verfasst von Yun Ding und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, 17 Yongwai Street, Nanchang, Jiangxi province, 3…. Hauptthemen laut MEDLINE: Adenocarcinoma, beta Catenin, Esophagogastric Junction, Phospholipid Hydroperoxide Glutathione Peroxidase. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Jiangxi Provincial Natural Science Foundation.
Abstract (Originalsprache)
Adenocarcinoma of the esophagogastric junction (AEG) has received widespread attention because of its increasing incidence. However, the molecular mechanism underlying tumor progression remains unclear. Here, we report that the downregulation of ubiquitin-specific peptidase 49 (USP49) promotes ferroptosis in OE33 and OE19 cells, thereby inhibiting cell proliferation in vitro and in vivo, whereas the overexpression of USP49 had the opposite effect. In addition, USP49 downregulation promoted AEG cell radiotherapy sensitivity. Moreover, overexpression of Glutathione PeroXidase 4 reversed the ferroptosis and proliferation inhibition induced by USP49 knockdown. Mechanistically, USP49 deubiquitinates and stabilizes Shc SH2-domain-binding protein 1, subsequently facilitating the entry of β-catenin into the nucleus to enhance Glutathione PeroXidase 4 transcriptional expression. Finally, high USP49 expression was correlated with shorter overall survival in patients with AEG. In summary, our findings identify USP49 as a novel regulator of ferroptosis in AEG cells, indicating that USP49 may be a potential therapeutic target in AEG.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, 17 Yongwai Street, Nanchang, Jiangxi province, 330006, China.
- Jiangxi Key Laboratory for Individualized Cancer Therapy, Nanchang, Jiangxi Province 330006, China.
ORCID-Profile: Jun Deng, Jianping Xiong
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Jiangxi Provincial Natural Science Foundation
Zitieren
APA
Ding, Y., Liu, Z., Dai, X., Ruan, R., Zhong, H., Wu, Z., Yao, Y., Chen, J., Deng, J., & Xiong, J. (2025). Ubiquitin-specific peptidase 49 promotes adenocarcinoma of the esophagogastric junction malignant progression via activating SHCBP1– β -catenin–GPX4 axis. Carcinogenesis. https://doi.org/10.1093/carcin/bgae060
Vancouver
Ding Y, Liu Z, Dai X, Ruan R, Zhong H, Wu Z, et al. Ubiquitin-specific peptidase 49 promotes adenocarcinoma of the esophagogastric junction malignant progression via activating SHCBP1– β -catenin–GPX4 axis. Carcinogenesis. 2025. doi:10.1093/carcin/bgae060
BibTeX
@article{Ding2025,
author = {Ding, Yun and Liu, Zhen and Dai, Xiaofeng and Ruan, Ruiwen and Zhong, Hongguang and Wu, Zhipeng and Yao, Yangyang and Chen, Jun and Deng, Jun and Xiong, Jianping},
title = {Ubiquitin-specific peptidase 49 promotes adenocarcinoma of the esophagogastric junction malignant progression via activating SHCBP1– β -catenin–GPX4 axis},
journal = {Carcinogenesis},
year = {2025},
doi = {10.1093/carcin/bgae060}
}
EUVIMED